Kamar N - Search Results

1

Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study.

Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salamé E, Neau-Cransac M, Vanlemmens C, Durand F, Pageaux GP, Hardwigsen J, Benkhatar Y, Derquenne F, Conti F. Saliba F, et al. Among authors: kamar n. Liver Int. 2022 Nov;42(11):2513-2523. doi: 10.1111/liv.15396. Epub 2022 Sep 1. Liver Int. 2022. PMID: 35962772 Free PMC article.

2

Assessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus.

Kamar N, Allard J, Ribes D, Durand D, Ader JL, Rostaing L. Kamar N, et al. Clin Nephrol. 2005 Feb;63(2):80-6. doi: 10.5414/cnp63080. Clin Nephrol. 2005. PMID: 15730049 Clinical Trial.

3

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.

Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L. Bumbea V, et al. Among authors: kamar n. Nephrol Dial Transplant. 2005 Nov;20(11):2517-23. doi: 10.1093/ndt/gfh957. Epub 2005 Jun 28. Nephrol Dial Transplant. 2005. PMID: 15985508

4

Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor- to sirolimus-based therapies in maintenance renal-transplant patients presenting with moderate renal insufficiency.

Kamar N, Frimat L, Blancho G, Wolff P, Delahousse M, Rostaing L. Kamar N, et al. Transpl Int. 2007 Feb;20(2):128-34. doi: 10.1111/j.1432-2277.2006.00409.x. Transpl Int. 2007. PMID: 17239020 Free article. Clinical Trial.

5

Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil.

Kamar N, Rostaing L. Kamar N, et al. Transplantation. 2008 Apr 27;85(8):1120-4. doi: 10.1097/TP.0b013e31816a8a1f. Transplantation. 2008. PMID: 18431231

6

Conversion from sirolimus to everolimus in maintenance renal transplant recipients within a calcineurin inhibitor-free regimen: results of a 6-month pilot study.

Kamar N, Jaafar A, Esposito L, Ribes D, Durand D, Di-Giambattista F, Tack I, Rostaing L. Kamar N, et al. Clin Nephrol. 2008 Aug;70(2):118-25. doi: 10.5414/cnp70118. Clin Nephrol. 2008. PMID: 18793527

7

T-cell function in maintenance renal transplant patients receiving mycophenolate mofetil and steroids with or without tacrolimus.

Canivet C, Böhler T, Galvani S, Therville N, Salvayre R, Durand D, Thomsen M, Rostaing L, Kamar N. Canivet C, et al. Among authors: kamar n. Transplant Proc. 2008 Dec;40(10):3422-3. doi: 10.1016/j.transproceed.2008.06.062. Transplant Proc. 2008. PMID: 19100403

8

Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.

Albano L, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrançois N, Charpentier B, Blanc AS, Di Giambattista F, Dantal J; RAD A2420 Study Group. Albano L, et al. Transplantation. 2009 Jul 15;88(1):69-76. doi: 10.1097/TP.0b013e3181aa7d87. Transplantation. 2009. PMID: 19584683 Clinical Trial.

9

Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients.

Calmus Y, Kamar N, Gugenheim J, Duvoux C, Ducerf C, Wolf P, Samuel D, Vanlemmens C, Neau-Cransac M, Salamé E, Chazouillères O, Declerck N, Pageaux GP, Dubel L, Rostaing L. Calmus Y, et al. Among authors: kamar n. Transplantation. 2010 Jun 27;89(12):1504-10. doi: 10.1097/TP.0b013e3181db8cf0. Transplantation. 2010. PMID: 20495510 Clinical Trial.

10

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.

Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, Merville P, Mengelle C, Rostaing L, Saint Marcoux F, Essig M, Rerolle JP, Cotin S, Germi R, Pillet S, Lebranchu Y, Turlure P, Alain S; French CMV Resistance Survey Study Group. Hantz S, et al. J Antimicrob Chemother. 2010 Dec;65(12):2628-40. doi: 10.1093/jac/dkq368. Epub 2010 Oct 20. J Antimicrob Chemother. 2010. PMID: 20961907 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

728 results

Search Page